Ng E, Gwini SM, Libianto R, Choy KW, Lu ZX, Shen J, Doery JCG, Fuller PJ, Yang J. (2023) Aldosterone, renin and ARR variability in screening for primary aldosteronism. The Journal of Clinical Endocrinology and Metabolism 108:33-41
Young MJ, Fuller PJ. (2023) Mineralocorticoids: physiology, metabolism, receptors and resistance. De Groot’s Endocrinology: Basic Science and Clinical Practice. RP Robertson (EIC). 8th Ed, Elsevier, Philadelphia
White VM, Alexiadis M, Eroh K, Ackermann K, Rodgers S, Langdale LM, Armour NE, Jobling TW, Fuller PJ, Chu S. (2023) How social media can help to understand treatment experiences of survivors of rare cancers: findings from the Granulosa Cell Tumor (GCT) Survivor Sisters Facebook® group member survey. Cancer 129:2224-2234
Libianto R, Russell GM, Stowasser M, Gwini SM, Nuttall P, Shen J, Young MJ, Fuller PJ, Yang J. (2022) Detecting primary aldosteronism in Australian primary care: a prospective study. Medical Journal of Australia 216:408-412
Yang J, Gwini SM, Beilin LJ, Schlaich S, Stowasser M, Young MJ, Fuller PJ, Mori TA. (2021) Relationship between the aldosterone-to-renin ratio and blood pressure in young adults: a longitudinal study. Hypertension 78:387-396
Alexiadis M, Rowley SM, Chu S, Leung DTH, Stewart CJR, Amarasinghe KC, Campbell IG, Fuller PJ. (2019) Mutational landscape of adult granulosa cell tumor of the ovary from whole exome and targeted TERT promoter sequencing. Molecular Cancer Research 17:177-185
Fuller PJ, Yao Y-Z, Jin R, He S, Martín-Fernández B, Young MJ, Smith BJ. (2019) Molecular evolution of the switch for progesterone and spironolactone from mineralocorticoid receptor agonist to antagonist. Proceedings of the National Academy of Sciences USA 116:18578-18583
Shen JZ, Morgan J, Tesch GH, Fuller PJ, Young MJ. (2014) CCL2-dependent macrophage recruitment is critical for mineralocorticoid receptor-mediated cardiac fibrosis, inflammation, and blood pressure responses in male mice. Endocrinology 155:1057-1066
Wong P, Fuller PJ, Gillespie MT, Kartsogiannis V, Kerr PG, Doery JCG, Paul E, Bowden DK, Strauss BJ, Milat F. (2014) Thalassemia bone disease: a 19-year longitudinal analysis. Journal of Bone and Mineral Research 29:2468-2473
Mond M, Alexiadis M, Eriksson N, Davis M, Muscat G, Fuller PJ, Gilfillan C. (2014) Nuclear receptor expression in human differentiated thyroid tumors. Thyroid 24:1000-1011
Rogerson FM, Yao Y-Z, Young MJ, Fuller PJ. (2014) Identification and characterization of a ligand-selective mineralocorticoid receptor coactivator. FASEB Journal 28:4200-4210
Yang J, Fuller PJ, Morgan J, Shibata H, McDonnell DP, Clyne CD, Young MJ. (2014) Use of phage display to identify novel mineralocorticoid receptor-interacting proteins. Molecular Endocrinology 28:1571-1584
Cluning C, Ward BK, Rea SL, Arulpragasam A, Fuller PJ, Ratajczak T. (2013) The helix 1-3 loop in the glucocorticoid receptor LBD is a regulatory element for FKBP cochaperones. Molecular Endocrinology 27:1020-1035
Jamieson S, Fuller PJ. (2013) Characterization of the inhibitor of kappaB kinase (IKK) complex in granulosa cell tumors of the ovary and granulosa cell tumor-derived cell lines. Hormones and Cancer 4:277-292
Muscat GEO, Eriksson NA, Byth K, Loi S, Graham D, Jindal S, Davis MJ, Clyne C, Funder JW, Simpson ER, Ragan MA, Kuczek E, Fuller PJ, Tilley WD, Leedman PJ, Clarke CL. (2013) Nuclear receptors as transcriptome: discriminant and prognostic value in breast cancer. Molecular Endocrinology 27:350-365
Jamieson S, Fuller PJ. (2012) Molecular pathogenesis of granulosa cell tumors of the ovary. Endocrine Reviews 33:109-144
Pippal JP, Cheung CMI, Yao YZ, Brennan FE, Fuller PJ. (2011) Characterization of the zebrafish (Danio rerio) mineralocorticoid receptor. Molecular and Cellular Endocrinology 332:58-66
Alexiadis M, Eriksson N, Jamieson S, Davis M, Drummond AE, Chu S, Clyne CD, Muscat GE, Fuller PJ. (2011) Nuclear receptor profiling of ovarian granulosa cell tumors. Hormones and Cancer 2:157-169
Jamieson S, Butzow R, Andersson N, Alexiadis M, Unkila-Kallio L, Heikinheimo M, Fuller PJ, Anttonen M. (2010) The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary: independent confirmation from two centers. Modern Pathology 23:1477-1485
Rickard AJ, Morgan J, Tesch G, Funder JW, Fuller PJ, Young MJ. (2009) Deletion of mineralocorticoid receptors from macrophages protects against DOC/salt-induced cardiac fibrosis and increased blood pressure. Hypertension 54:537-543
Pippal JB, Yao Y, Rogerson FM, Fuller PJ. (2009) Structural and functional characterization of the interdomain interaction in the mineralocorticoid receptor. Molecular Endocrinology 23:1360-1370
Chu S, Alexiadis M, Fuller PJ. (2008) Expression, mutational analysis, and in vitro response of imatinib mesylate and nilotinib target genes in ovarian granulosa cell tumors. Gynecologic Oncology 108:182-190
Rogerson FM, Yao YZ, Elsass RE, Dimopoulos N, Smith BJ, Fuller PJ. (2007) A critical region in the mineralocorticoid receptor for aldosterone binding and activation by cortisol: evidence for a common mechanism governing ligand binding specificity in steroid hormone receptors. Molecular Endocrinology 21:817-828
